Deferred Compensation Arrangement With Individual, Cash Awards Granted, Percentage Grant Date

No definition available.

Name:	mtor_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentageGrantDate
Namespace Prefix:	mtor_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Deferred Compensation Arrangement With Individual, Vesting, Percentage

+ References

No definition available.

+ Details

Name:	mtor_DeferredCompensationArrangementWithIndividualVestingPercentage
Namespace Prefix:	mtor_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Dilutive impact of restricted shares and share units during the period

+ References

No definition available.

+ Details

Name:	mtor_ImpactOfRestrictedSharesAndShareUnits
Namespace Prefix:	mtor_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Potential Effect Of Restricted Shares And Share Units, And Performance Shares Excluded From Diluted Earnings Per Share Computation

+ References

No definition available.

+ Details

Name:	mtor_PotentialEffectOfRestrictedSharesAndShareUnitsAndPerformanceSharesExcludedFromDilutedEarningsPerShareComputation
Namespace Prefix:	mtor_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Performance Period

+ References

No definition available.

+ Details

Name:	mtor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPerformancePeriod
Namespace Prefix:	mtor_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The per share price that the individual must pay to acquire shares under the deferred compensation arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Net number of non-option equity instruments granted to participants.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of vesting of share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=mtor_SevenAndSevenEighthsPercentConvertibleNotesDue2026Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=mtor_GoalfourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=mtor_GoalthreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=mtor_GoaltwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=mtor_GoaloneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Earnings per Share - Additional information (Details) - USD ($) $ / shares in Units, $ in Millions					1 Months Ended				3 Months Ended
	Dec. 01, 2017	Dec. 01, 2016	Dec. 01, 2015	Dec. 01, 2014	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2015	Nov. 30, 2014	Dec. 31, 2017	Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential effect of restricted shares and share units, and performance shares excluded from diluted earnings per share computation									1,700,000
Impact of restricted shares, restricted share units and performance share units (in shares)									0	1,400,000
Share-based compensation expense									$ 5	$ 3
Potential effect of shares excluded from diluted earnings calculation (in shares)									1,000,000
Convertible Notes \| 7.875% Convertible Notes Due 2026
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Interest rate									7.875%
Executive Officer
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number or shares issuable per performance share unit (in shares)						1	1	1
Executive Officer \| Performance Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise price (in usd per share)	$ 24.79	$ 12.77	$ 10.51	$ 13.74
Executive Officer \| Performance Shares \| Performance period of October 1, 2017 to September 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance period					3 years
Shares authorized for grant (in shares)					300,000
Executive Officer \| Performance Shares \| Performance period of October 1, 2017 to September 30, 2020 \| Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									0.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2017 to September 30, 2020 \| Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									200.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2017 to September 30, 2020 \| Performance Objective One
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									50.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2017 to September 30, 2020 \| Performance Objective Two
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									50.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance period						3 years
Shares authorized for grant (in shares)						600,000
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019 \| Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									0.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019 \| Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									200.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019 \| Performance Objective One
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									50.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019 \| Performance Objective Two
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									25.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2016 to September 30, 2019 \| Performance Objective Three
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									25.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2015 to September 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance period							3 years
Shares authorized for grant (in shares)							700,000
Executive Officer \| Performance Shares \| Performance period of October 1, 2015 to September 30, 2018 \| Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									0.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2015 to September 30, 2018 \| Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance-based vesting percentage									200.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2015 to September 30, 2018 \| Performance Objective One
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									50.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2015 to September 30, 2018 \| Performance Objective Two
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Award vesting rights percentage									50.00%
Executive Officer \| Performance Shares \| Performance period of October 1, 2014 to September 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Performance period									3 years
Payout of performance share units	65.00%
Executive Officer \| Restricted Share Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise price (in usd per share)		$ 12.77	$ 10.51	$ 13.74
Shares granted (in shares)					300,000	500,000	500,000	400,000
Vesting period	3 years	3 years	3 years	3 years